Biotech
-
NanoViricides to Produce Broad Spectrum Antiviral Clinical Trial Candidates for COVID-19
The COVID-19 coronavirus is spreading rapidly across the globe despite persistent efforts from Governments to contain its spread.
Read More » -
Avivagen’s OxC-beta™ Livestock product May Prevent Future Outbreaks Like The Wuhan Coronavirus
The emerging crisis of the Wuhan coronavirus in China has global implications with over 2,126 deaths worldwide and over 75,700…
Read More » -
Biotech Stocks To The Rescue: The Race to Stop The Wuhan Virus
The Wuhan coronavirus is a brand new respiratory virus that has emerged in China in a metropolis by the identical…
Read More » -
Moderna Gains 18% on positive CMV vaccine data
Moderna (NASDAQ:MRNA) gained 16% in heavy after-hours buying and selling exercise at the moment. The firm posted the positive Phase…
Read More » -
NanoViricides: Grab This Biopharma Player While Inexpensive
Investment timing is among the most important ideas associated to the world of stock market investing. While its software is…
Read More » -
NanoViricides: A Unicorn For Biotech Investors
The OTC markets are filled with zero-revenue biotech companies looking for research funding through issuance of equity but, it is…
Read More » -
NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter
Latham, New York: AngioDynamics, Inc. (NASDAQ:ANGO) is a number one supplier of modern, minimally invasive medical units utilized by skilled…
Read More » -
Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an organization identified for locating novel drug targets and drug candidates developed from state-of-the-art medicinal…
Read More » -
Aerie Pharmaceuticals Delivers Mixed Result; Focus On International Expansion
Durhan, NC: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a scientific stage pharmaceutical firm targeted on offering therapies for the therapy of eye-related…
Read More » -
Tackling triple-negative breast cancer by blocking 2 key survival pathways
[ad_1] Triple-negative breast cancer is the hardest type of the illness to deal with as a result of it lacks…
Read More »
